P2RY2 and neoplasm: Tumor growth in mice injected with MDA-MB-231-P2Y2R-shRNA was significantly decreased, and their body weights were increased compared to those of mice injected with MDA-MB-231-EV by 2 weeks post-injection (Figure 6A-C).